IRIS Accounts Production v25.3.0.601 12371326 director 1.3.24 28.2.25 28.2.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh123713262024-02-29123713262025-02-28123713262024-03-012025-02-28123713262023-02-28123713262023-03-012024-02-29123713262024-02-2912371326ns15:EnglandWales2024-03-012025-02-2812371326ns14:PoundSterling2024-03-012025-02-2812371326ns10:Director12024-03-012025-02-2812371326ns10:PrivateLimitedCompanyLtd2024-03-012025-02-2812371326ns10:SmallEntities2024-03-012025-02-2812371326ns10:AuditExemptWithAccountantsReport2024-03-012025-02-2812371326ns10:SmallCompaniesRegimeForDirectorsReport2024-03-012025-02-2812371326ns10:SmallCompaniesRegimeForAccounts2024-03-012025-02-2812371326ns10:FullAccounts2024-03-012025-02-2812371326ns10:RegisteredOffice2024-03-012025-02-2812371326ns5:CurrentFinancialInstruments2025-02-2812371326ns5:CurrentFinancialInstruments2024-02-2912371326ns5:Non-currentFinancialInstruments2025-02-2812371326ns5:Non-currentFinancialInstruments2024-02-2912371326ns5:ShareCapital2025-02-2812371326ns5:ShareCapital2024-02-2912371326ns5:RetainedEarningsAccumulatedLosses2025-02-2812371326ns5:RetainedEarningsAccumulatedLosses2024-02-2912371326ns5:PlantMachinery2024-03-012025-02-2812371326ns5:MotorVehicles2024-03-012025-02-2812371326ns5:ComputerEquipment2024-03-012025-02-2812371326ns5:PlantMachinery2024-02-2912371326ns5:MotorVehicles2024-02-2912371326ns5:ComputerEquipment2024-02-2912371326ns5:PlantMachinery2025-02-2812371326ns5:MotorVehicles2025-02-2812371326ns5:ComputerEquipment2025-02-2812371326ns5:PlantMachinery2024-02-2912371326ns5:MotorVehicles2024-02-2912371326ns5:ComputerEquipment2024-02-2912371326ns5:WithinOneYearns5:CurrentFinancialInstruments2025-02-2812371326ns5:WithinOneYearns5:CurrentFinancialInstruments2024-02-2912371326ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2025-02-2812371326ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-02-2912371326ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-02-2812371326ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-02-29123713261ns10:Director12024-02-29123713261ns10:Director12023-02-28123713261ns10:Director12024-03-012025-02-28123713261ns10:Director12023-03-012024-02-29123713261ns10:Director12025-02-28123713261ns10:Director12024-02-29
REGISTERED NUMBER: 12371326 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 28 FEBRUARY 2025

FOR

LYNNE CHAPMAN REPRODUCTIVE HEALTH (LCRH)
LTD

LYNNE CHAPMAN REPRODUCTIVE HEALTH (LCRH)
LTD (REGISTERED NUMBER: 12371326)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Chartered Accountants' Report 6

LYNNE CHAPMAN REPRODUCTIVE HEALTH (LCRH)
LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 28 FEBRUARY 2025







DIRECTOR: L A Chapman





REGISTERED OFFICE: The Beaconsfield Clinic
Windsor End
Beaconsfield
Buckinghamshire
HP9 2JW





REGISTERED NUMBER: 12371326 (England and Wales)





ACCOUNTANTS: Ashdown Hurrey
Chartered Accountants & Business Advisers
20 Havelock Road
Hastings
East Sussex
TN34 1BP

LYNNE CHAPMAN REPRODUCTIVE HEALTH (LCRH)
LTD (REGISTERED NUMBER: 12371326)

BALANCE SHEET
28 FEBRUARY 2025

28.2.25 29.2.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 80,868 105,793

CURRENT ASSETS
Debtors 5 536,718 466,203
Cash at bank 137,615 55,429
674,333 521,632
CREDITORS
Amounts falling due within one year 6 600,307 625,560
NET CURRENT ASSETS/(LIABILITIES) 74,026 (103,928 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

154,894

1,865

CREDITORS
Amounts falling due after more than one
year

7

(31,785

)

(83,678

)

PROVISIONS FOR LIABILITIES (6,544 ) (8,806 )
NET ASSETS/(LIABILITIES) 116,565 (90,619 )

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 116,564 (90,620 )
SHAREHOLDERS' FUNDS 116,565 (90,619 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 10 November 2025 and were signed by:



L A Chapman - Director


LYNNE CHAPMAN REPRODUCTIVE HEALTH (LCRH)
LTD (REGISTERED NUMBER: 12371326)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

1. STATUTORY INFORMATION

Lynne Chapman Reproductive Health (LCRH) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The director has made an assessment about the company's ability to continue as a going concern and she does not consider there to be any material uncertainties.
As a result the going concern basis of accounting has been adopted.

Turnover
Turnover represents invoiced sale of health services exempt from VAT and excluding discounts and other taxes.
Turnover is recognised as services are rendered; for multi-cycle packages revenue is deferred until subsequent cycles are completed.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2024 - 7 ) .

LYNNE CHAPMAN REPRODUCTIVE HEALTH (LCRH)
LTD (REGISTERED NUMBER: 12371326)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2025

4. TANGIBLE FIXED ASSETS
Plant and Motor Computer
machinery vehicles equipment Totals
£    £    £    £   
COST
At 1 March 2024
and 28 February 2025 77,880 82,490 7,023 167,393
DEPRECIATION
At 1 March 2024 28,746 29,588 3,266 61,600
Charge for year 9,827 13,226 1,872 24,925
At 28 February 2025 38,573 42,814 5,138 86,525
NET BOOK VALUE
At 28 February 2025 39,307 39,676 1,885 80,868
At 29 February 2024 49,134 52,902 3,757 105,793

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.25 29.2.24
£    £   
Trade debtors 139,514 44,117
Other debtors 7,969 47,274
Directors' current accounts 847 274,485
Directors' loan accounts 280,000 -
Tax 94,500 92,639
Prepayments and accrued income 13,888 7,688
536,718 466,203

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.25 29.2.24
£    £   
Bank loans and overdrafts (see note 8) 10,329 10,076
Hire purchase contracts 33,763 27,245
Trade creditors 379,303 299,031
Tax 160,644 97,624
Social security and other taxes 14,000 22,055
Deferred income - 129,868
Accrued expenses 2,268 39,661
600,307 625,560

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
28.2.25 29.2.24
£    £   
Bank loans (see note 8) 7,172 17,424
Hire purchase contracts 24,613 66,254
31,785 83,678

LYNNE CHAPMAN REPRODUCTIVE HEALTH (LCRH)
LTD (REGISTERED NUMBER: 12371326)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2025

8. LOANS

An analysis of the maturity of loans is given below:

28.2.25 29.2.24
£    £   
Amounts falling due within one year or on demand:
Bank loans 10,329 10,076

Amounts falling due between one and two years:
Bank loans - 1-2 years 7,172 10,331

Amounts falling due between two and five years:
Bank loans - 2-5 years - 7,093

9. SECURED DEBTS

The following secured debts are included within creditors:

28.2.25 29.2.24
£    £   
Hire purchase contracts 58,376 93,499

Hire purchase loans are secured against their respective underlying assets included within tangible fixed assets.

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 28 February 2025 and 29 February 2024:

28.2.25 29.2.24
£    £   
L A Chapman
Balance outstanding at start of year 274,485 203,465
Amounts advanced 6,362 77,020
Amounts repaid - (6,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 280,847 274,485

11. RELATED PARTY DISCLOSURES

At the balance sheet date, L Chapman owed the company £280,847 (2024: £274,485). Interest has been charged at 2.25%, £847 was repaid subsequent to the balance sheet date leaving the balance repayable upon demand.

CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE UNAUDITED FINANCIAL STATEMENTS OF
LYNNE CHAPMAN REPRODUCTIVE HEALTH (LCRH)
LTD

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Lynne Chapman Reproductive Health (LCRH) Ltd for the year ended 28 February 2025 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at icaew.com/membershandbook.

This report is made solely to the director of Lynne Chapman Reproductive Health (LCRH) Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Lynne Chapman Reproductive Health (LCRH) Ltd and state those matters that we have agreed to state to the director of Lynne Chapman Reproductive Health (LCRH) Ltd in this report in accordance with icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Lynne Chapman Reproductive Health (LCRH) Ltd and its director for our work or for this report.

It is your duty to ensure that Lynne Chapman Reproductive Health (LCRH) Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Lynne Chapman Reproductive Health (LCRH) Ltd. You consider that Lynne Chapman Reproductive Health (LCRH) Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Lynne Chapman Reproductive Health (LCRH) Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Ashdown Hurrey
Chartered Accountants & Business Advisers
20 Havelock Road
Hastings
East Sussex
TN34 1BP


10 November 2025